The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines

Abstract

The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly in China, and has developed to be a Public Health Emergency of International Concern. However, no specific antiviral treatments or vaccines are available yet. This work aims to share strategies and candidate antigens to develop safe and effective vaccines against SARS-CoV-2.

References 25

1. 1.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1056/nejmoa2001316

2. 2.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.46234/ccdcw2020.082

3. 3.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

4. 4.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1016/s0140-6736(20)30183-5

5. 5.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1148/radiol.2020200323

6. 6.
   Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season · 2018

   No notice
7. 7.
   A new coronavirus associated with human respiratory disease in China · 2020

   Corrected
8. 8.
   SARS Vaccine Development · 2005

   No notice
9. 9.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library10.1128/jvi.03566-14

10. 10.
    Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan · 2020

    Corrected
11. 11.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1046/j.1365-2893.1998.00106.x

12. 12.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1038/nrmicro2090

13. 13.
    Coronavirus envelope protein: current knowledge · 2019

    No notice
14. 14.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1038/nrmicro3143

15. 15.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.molimm.2005.11.005

16. 16.
    Return of the Coronavirus: 2019-nCoV · 2020

    No notice
17. 17.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.ymeth.2015.04.037

18. 18.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.00127-20

19. 19.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/s0140-6736(04)16501-x

20. 20.
    From SARS to MERS, Thrusting Coronaviruses into the Spotlight · 2019

    No notice
21. 21.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1056/nejmoa2001191

22. 22.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1038/nature02463

23. 23.
    New Vaccine Technologies to Combat Outbreak Situations · 2018

    No notice
24. 24.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1021/acs.nanolett.7b03893

25. 25.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1586/erv.09.43

Cited by papers we hold 6

• A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants · 2022
  No notice
• An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study · 2021
  No notice
• The COVID-19 pandemic: a global health crisis · 2020
  No notice
• SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions · 2020
  No notice
• COVID-19: animals, veterinary and zoonotic links · 2020
  No notice
• An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.